The role of the c-myc oncogene has been little investigated in uveal m
elanoma. In this study an analysis of c-myc oncoprotein expression was
undertaken using flow cytometry in 71 patients with posterior uveal m
elanoma. Nuclear c-myc oncoprotein was detected in all of the tumours,
and survival analysis revealed a significant association between high
oncoprotein positivity and improved survival (log rank test: chi(2) =
6.47, P = 0.01). Multifactorial analysis using Cox's proportional haz
ards model revealed nuclear c-myc oncoprotein to be an independent pro
gnostic marker more accurate than other clinicopathological parameters
(log rank test: chi(2) = 6.61, P = 0.01). However, this result of hig
h oncoprotein expression correlating with improved outcome is surprisi
ng and in contrast to our previous studies using the same method on cu
taneous melanoma, where high levels of nuclear c-myc expression have b
een found to correlate with poor outcome both in primary and secondary
disease. This study suggests that the pattern of oncogene expression
in uveal melanoma is distinct from cutaneous melanoma and that the und
erlying biology of these tumours is different. (C) 1998 Lippincott-Rav
en Publishers.